|
1
|
Amuzu P, Pan X, Hou X, Sun J, Jakada MA, Odigie E, Xu D, Lai D, Zhou L. Recent Updates on the Secondary Metabolites from Fusarium Fungi and Their Biological Activities (Covering 2019 to 2024). J Fungi (Basel) 2024; 10:778. [PMID: 39590697 PMCID: PMC11596042 DOI: 10.3390/jof10110778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2024] [Revised: 10/26/2024] [Accepted: 11/07/2024] [Indexed: 11/28/2024] Open
Abstract
Fusarium species are commonly found in soil, water, plants, and animals. A variety of secondary metabolites with multiple biological activities have been recently isolated from Fusarium species, making Fusarium fungi a treasure trove of bioactive compounds. This mini-review comprehensively highlights the newly isolated secondary metabolites produced by Fusarium species and their various biological activities reported from 2019 to October 2024. About 276 novel metabolites were revealed from at least 21 Fusarium species in this period. The main metabolites were nitrogen-containing compounds, polyketides, terpenoids, steroids, and phenolics. The Fusarium species mostly belonged to plant endophytic, plant pathogenic, soil-derived, and marine-derived fungi. The metabolites mainly displayed antibacterial, antifungal, phytotoxic, antimalarial, anti-inflammatory, and cytotoxic activities, suggesting their medicinal and agricultural applications. This mini-review aims to increase the diversity of Fusarium metabolites and their biological activities in order to accelerate their development and applications.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Ligang Zhou
- Department of Plant Pathology, College of Plant Protection, China Agricultural University, Beijing 100193, China; (P.A.); (X.P.); (X.H.); (J.S.); (M.A.J.); (E.O.); (D.X.); (D.L.)
| |
Collapse
|
|
2
|
Li Y, Zhu G, Wang J, Yu J, Ye K, Xing C, Ren B, Zhu B, Chen S, Lai L, Li Y, Hsiang T, Zhang L, Liu X, Zhang J. New Polyketide Congeners with Antibacterial Activities from an Endophytic Fungus Stemphylium globuliferum 17035 (China General Microbiological Culture Collection Center No. 40666). J Fungi (Basel) 2024; 10:737. [PMID: 39590657 PMCID: PMC11595617 DOI: 10.3390/jof10110737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2024] [Revised: 10/18/2024] [Accepted: 10/22/2024] [Indexed: 11/28/2024] Open
Abstract
Four new polyketides, heterocornol Y (1), stemphyindan (2), pestalospirane C (3), and stemphyspyrane (4), along with five known ones (5-9) were isolated from the endophytic fungus Stemphylium globuliferum 17035 (SG17035) based on the One Strain Many Compounds (OSMAC) strategy allied with an LC-MS approach. These structures were elucidated through extensive spectroscopic analyses, single-crystal X-ray diffraction, and 13C NMR-DP4 analysis. Pestalospirane C (3) and stemphyspyrane (4) featured unprecedented spiroketal skeletons. In addition, the putative biosynthetic logic for compounds 1-4 was proposed. Antibacterial and cytotoxic activities of compounds 1-9 were evaluated. Stemphyspyrane (4) displayed promising antibacterial activity against different pathogens, especially against Staphylococcus aureus, Porphyromonas gingivalis, and methicillin-resistant Staphylococcus aureus (MRSA) with MIC values of 3.125 μM, 6.25 μM, and 12.5 μM, respectively. It is promising as an antibacterial agent for further optimization.
Collapse
Affiliation(s)
- Yingying Li
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Guoliang Zhu
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Jing Wang
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Junjie Yu
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Ke Ye
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Cuiping Xing
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Biao Ren
- State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China;
| | - Bin Zhu
- Laboratory of Pharmaceutical Crystal Engineering & Technology, Engineering Research Centre of Pharmaceutical Process Chemistry, Ministry of Education, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China;
| | - Simin Chen
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Lijun Lai
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Yue Li
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Tom Hsiang
- School of Environmental Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada;
| | - Lixin Zhang
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Xueting Liu
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| | - Jingyu Zhang
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; (Y.L.); (G.Z.); (J.W.); (J.Y.); (K.Y.); (C.X.); (S.C.); (L.L.); (Y.L.); (L.Z.); (X.L.)
| |
Collapse
|
|
3
|
Elkharsawy H, Eldomany RA, Mira A, Soliman AF, Amir M, El-Sharkawy S. New neuroprotective derivatives of cinnamic acid by biotransformation. Food Funct 2024; 15:4323-4337. [PMID: 38530276 DOI: 10.1039/d3fo04802k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/27/2024]
Abstract
Microbial transformation is extensively utilized to generate new metabolites in bulk amounts with more specificity and improved activity. As cinnamic acid was reported to exhibit several important pharmacological properties, microbial transformation was used to obtain its new derivatives with enhanced biological activities. By manipulating the 2-stage fermentation protocol of biotransformation, five metabolites were produced from cinnamic acid. Two of them were new derivatives; N-propyl cinnamamide 2̲ and 2-methyl heptyl benzoate 3̲ produced by Alternaria alternata. The other 3 metabolites, p-hydroxy benzoic acid 4̲, cinnamyl alcohol 5̲ and methyl cinnamate 6̲, were produced by Rhodotorula rubra, Rhizopus species and Penicillium chrysogeneum, respectively. Cinnamic acid and its metabolites were evaluated for their cyclooxygenase (COX) and acetylcholinesterase (AChE) inhibitory activities. Protection against H2O2 and Aβ1-42 induced-neurotoxicity in human neuroblastoma (SH-SY5Y) cells was also monitored. Metabolite 4̲ was more potent as a COX-2 inhibitor than the parent compound with an IC50 value of 1.85 ± 0.07 μM. Out of the tested compounds, only metabolite 2̲ showed AChE inhibitory activity with an IC50 value of 8.27 μM. These results were further correlated with an in silico study of the binding interactions of the active metabolites with the active sites of the studied enzymes. Metabolite 3̲ was more potent as a neuroprotective agent against H2O2 and Aβ1-42 induced-neurotoxicity than catechin and epigallocatechin-3-gallate as positive controls. This study suggested the two new metabolites 2̲ and 3̲ along with metabolite 4̲ as potential leads for neurodegenerative diseases associated with cholinergic deficiency, neurotoxicity or neuroinflammation.
Collapse
Affiliation(s)
- Hadeer Elkharsawy
- Department of Pharmacognosy, Faculty of Pharmacy, Kafr El-Sheikh University, Kafr El-Sheikh 33516, Egypt
| | - Ramadan A Eldomany
- Department of Microbiology and Immunology, Faculty of Pharmacy, Kafr El-Sheikh University, Kafr El-Sheikh 33156, Egypt
| | - Amira Mira
- Department of Pharmacognosy & Pharmaceutical Chemistry, College of Dentistry & Pharmacy. Buraydah Private Colleges, Buraydah 51418, Kingdom of Saudi Arabia.
- Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
| | - Amal F Soliman
- Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
- Pharmacognosy Department, Faculty of Pharmacy, Mansoura National University, Gamasa 7731168, Egypt
| | - Mohamed Amir
- Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
| | - Saleh El-Sharkawy
- Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
| |
Collapse
|
|
4
|
Xu M, Huang Z, Zhu W, Liu Y, Bai X, Zhang H. Fusarium-Derived Secondary Metabolites with Antimicrobial Effects. Molecules 2023; 28:molecules28083424. [PMID: 37110658 PMCID: PMC10142451 DOI: 10.3390/molecules28083424] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Revised: 04/07/2023] [Accepted: 04/11/2023] [Indexed: 04/29/2023] Open
Abstract
Fungal microbes are important in the creation of new drugs, given their unique genetic and metabolic diversity. As one of the most commonly found fungi in nature, Fusarium spp. has been well regarded as a prolific source of secondary metabolites (SMs) with diverse chemical structures and a broad spectrum of biological properties. However, little information is available concerning their derived SMs with antimicrobial effects. By extensive literature search and data analysis, as many as 185 antimicrobial natural products as SMs had been discovered from Fusarium strains by the end of 2022. This review first provides a comprehensive analysis of these substances in terms of various antimicrobial effects, including antibacterial, antifungal, antiviral, and antiparasitic. Future prospects for the efficient discovery of new bioactive SMs from Fusarium strains are also proposed.
Collapse
Affiliation(s)
- Meijie Xu
- School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China
| | - Ziwei Huang
- School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China
| | - Wangjie Zhu
- School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China
| | - Yuanyuan Liu
- School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China
| | - Xuelian Bai
- College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China
| | - Huawei Zhang
- School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China
| |
Collapse
|